Leading provider of antibody reactome services. Catalog antigen libraries include human proteome, virome & allergome. Custom library creation also possible!
Baltimore, MD
Joined January 2024
- Tweets213
- Following183
- Followers107
- Likes527
Infinity Bio Inc. retweeted
We've just launched the first large, site-less (home, direct to participant) randomized trial for treatment of #LongCovid, testing tirzepatide (a GLP-1 drug) vs placebo. Please help spread the word scripps.edu/news-and-events/…
Infinity Bio Inc. retweeted
The Long COVID Treatment Trial – Tirzepatide (LoCITT-T) is officially open for enrollment for people with Long COVID in:
Alabama, Alaska, California, Florida, Illinois, Indiana, Michigan, Ohio, Pennsylvania, Texas, Utah
longcovid.scripps.edu/locitt…
1/16
Infinity Bio Inc. retweeted
The proteins in our blood as fingerprints for 59 diseases and health @ScienceMagazine
science.org/doi/10.1126/scie…
Infinity Bio Inc. retweeted
Proteins are still pretty hard to measure.
Traditional approaches (e.g., phage, yeast, ribosome display) rely on DNA barcodes + NGS, but face throughput constraints + quirks.
Infinity Bio has created a "self-assembling" DNA-barcoded libraries. The goal: screen drugs against all known allergens, human viruses & human proteins
Infinity Bio Inc. retweeted
A new Science #Immunology study finds that the immune landscape is altered in deep cervical lymph nodes from patients with #MultipleSclerosis, including altered memory B cells and EBV-targeting CD8 T cells. scim.ag/3Qsi2dS
Infinity Bio Inc. retweeted
🎧Simplify Complexity with Ben Larman
Infinity Bio is thrilled to share this insightful conversation from the "Management Blueprint Podcast” featuring Dr. Ben Larman, our CSO/Founder and a pioneer in the antibody reactome profiling space.
In this episode, Dr. Larman discusses his innovative and efficient MIPSA technology that overcomes the challenges of previous antibody reactome profiling technologies.
Tune in to discover:
✅ The unique insights revealed by the antibody reactome and its untold story
✅ How decoding the antibody reactome can revolutionize your research
✅ The power of pairing antibody reactome data with omics studies for deeper, multidimensional analysis
🔗 Catch the podcast here: tinyurl.com/av7mvvkj
#podcast #antibody #antibodies #immunology #immune
Infinity Bio Inc. retweeted
Infinity Bio is thrilled to be part of the Precision Medicine World Conference (PMWC) 2025! Visit us at Booth C842 to connect with our team and learn about our cutting-edge antibody reactome profiling technology. Don’t miss Joel Credle, Ph.D., our Director of R&D, presenting "Measuring the Circulating Antibody Reactome for Translational Biomarker Research" on
Day 2, February 6, at 9:30 AM.
Joel Credle, Ph.D. is the Director of R&D at Infinity Bio and an expert in molecular biology with over 15 years of experience. He has pioneered innovations such as MIPSA, a next-generation molecular display technology.
Check out the 4 comprehensive MIPSA libraries led by Joel Credle, Ph.D. : tinyurl.com/4PROFILERSTW
#antibodies #antibody #PMWC2025 #PrecisionMedicine #CancerResearch #biomarkers #immunology #immune
Infinity Bio Inc. retweeted
A new @SciImmunology study finds that humans without known exposure to bird flu have antibodies that can recognize H5-specific hemagglutinin and neutralize highly pathogenic H5N1. scim.ag/4hwAKNc
